Edap Tms S.A. (NASDAQ:EDAP) Expected to Post Earnings of -$0.01 Per Share – Defense World

Wall Street analysts predict that Edap Tms S.A. (NASDAQ:EDAP Get Rating) will post earnings per share of ($0.01) for the current quarter, Zacks reports. Two analysts have made estimates for Edap Tms earnings. The highest EPS estimate is $0.02 and the lowest is ($0.04). Edap Tms reported earnings per share of $0.03 in the same quarter last year, which indicates a negative year-over-year growth rate of 133.3%. The company is expected to issue its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that Edap Tms will report full year earnings of ($0.08) per share for the current financial year, with EPS estimates ranging from ($0.13) to ($0.03). For the next financial year, analysts forecast that the firm will post earnings of ($0.04) per share, with EPS estimates ranging from ($0.11) to $0.03. Zacks Investment Researchs earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for Edap Tms.

Edap Tms (NASDAQ:EDAP Get Rating) last released its quarterly earnings data on Wednesday, March 30th. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. Edap Tms had a net margin of 1.51% and a return on equity of 1.53%. During the same period in the prior year, the firm earned $0.03 earnings per share.

Shares of EDAP remained flat at $$7.25 during mid-day trading on Friday. 60,951 shares of the stock traded hands, compared to its average volume of 67,022. The stock has a market cap of $241.50 million, a price-to-earnings ratio of 725.73 and a beta of 1.40. The company has a fifty day simple moving average of $7.27 and a 200 day simple moving average of $6.52. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.75 and a quick ratio of 3.34. Edap Tms has a twelve month low of $5.00 and a twelve month high of $7.88.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Soleus Capital Management L.P. grew its position in Edap Tms by 6.5% in the 4th quarter. Soleus Capital Management L.P. now owns 3,148,609 shares of the medical equipment providers stock worth $18,860,000 after purchasing an additional 192,242 shares during the last quarter. Fosun International Ltd boosted its holdings in shares of Edap Tms by 1.7% in the fourth quarter. Fosun International Ltd now owns 179,039 shares of the medical equipment providers stock valued at $949,000 after acquiring an additional 3,000 shares in the last quarter. Envestnet Asset Management Inc. bought a new position in shares of Edap Tms in the fourth quarter valued at approximately $94,000. Toroso Investments LLC bought a new position in shares of Edap Tms in the third quarter valued at approximately $126,000. Finally, Morgan Stanley boosted its holdings in shares of Edap Tms by 92.2% in the third quarter. Morgan Stanley now owns 1,497,285 shares of the medical equipment providers stock valued at $9,553,000 after acquiring an additional 718,460 shares in the last quarter. Hedge funds and other institutional investors own 27.20% of the companys stock.

Edap Tms Company Profile (Get Rating)

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution.